Skip to content
★ Sign in to follow
Aekyungchemical Co., Ltd. logo

Aekyungchemical Co., Ltd. Stock: price and insider trades · South Korea

애경케미칼

KR·Mcap ₩473.3BChemicals

No insider purchase over the last 90 days. The latest, by 국민연금공단, was filed 07 Oct 2024.

Aekyungchemical Co., Ltd.: what insiders have been doing

Aekyungchemical Co., Ltd. is a Chemicals company. Its directors and officers file their transactions with DART (FSS). Between 31 October 2025 and 31 October 2026, 2 insiders published 16 filings.

No insider bought on the market over the period, while 1 insider filed 3 sales. The amount is not disclosed for 3 filings.

Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 16 filings, this issuer sits above that mark. Since 2021, the database holds 9 purchases and 7 sales by insiders of the company.

Between a trade and the moment it shows up on DART (FSS), the median delay is 2 days. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

Other companies in the same sector with recent insider buying flagged by our signals: Symrise AG and Titan. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
71
Thresholds
n/a
Buy Volume
€343,391
9 ops. · all time
Sell Volume
€3M
7 ops. · all time

Who traded when

BuySale
Ak홀딩스4 sales
국민연금공단1 sale

Since the insiders bought

  • Filed 07 Oct 2024 · 763 days ago · €119k
    +4.3%
    Entry ₩10,480 · Close at T+365 ₩10,930
  • Filed 10 May 2024 · 913 days ago
    -9.5%
    Entry ₩12,840 · Close at T+365 ₩11,620

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 23,626 of 26,913 companies
24.0
score / 100
Value
28
Quality
21
FCF yld-17%
Earn yld-0.7%
EV/EBITDA12.5x
ROE2.5%
Gross mgn8.2%
Net mgn-0.2%
Debt/EBITDA6.7x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩9,800
Analyst consensus
·
Income statement
Revenue₩1.5T
Gross profit₩119B8% margin
EBITDA₩75.8B5% margin
Net income-₩2.9B1.3% margin
Valuation
Beta0.48
Balance sheet & cash
Market cap₩473.3B
Total debt₩504.9B
Free Cash Flow-₩77.2B
Debt / Equity80%
Profitability & ownership
ROE2.5%
ROA1.5%
% insiders62.2%
% institutions2.3%
Last declaration on 30 June 2026
Declarations76 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    대량보유자Executives
    €330kest.0DART
    48,582 sharesKRXDART:20260601001894
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260428000580
  • ●
    Executives
    0DART
    0KRXDART:20260423000725
  • ▼
    Executives
    €76kest.0DART
    8,743 sharesKRXDART:20260402002760
  • ●
    Executives
    0DART
    0KRXDART:20260319000533
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260304000871
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ▼
    대량보유자Executives
    €27kest.0DART
    4,260 sharesKRXDART:20251204000484
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART
  • ●
    Executives
    Executives
    0DART

25 of 76 declarations

About Aekyungchemical Co., Ltd.

Aekyung Chemical is a South Korean company specializing in chemicals and materials. It is listed on the XKRX.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations